Dr. Pavan Kumar Mankal, MD

Dr. Mankal practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Mankal's NPI, 1760777320, was assigned on June 12, 2011. Dr. Mankal graduated from Ben Gurion University of the Negev in 2011. Dr. Mankal holds California license 128433.

Dr. Mankal's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Mankal's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Mankal is also affiliated with Mercy Hospital Oklahoma City. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Mankal to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mankal practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mankal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mankal is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mankal's licenses on file in 3 states: California, Illinois and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroenteritis among the conditions Dr. Mankal treats.

CMS data shows 1,051 Medicare services from Dr. Mankal across 16 procedure codes in 2024, for 288 Medicare patients. Medicare paid $97,944 for them.

CMS counts 288 Medicare patients who saw Dr. Mankal in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mankal's median patient age at 67, with 60% women.

In 2024, Dr. Mankal wrote 770 Medicare Part D claims for 226 patients. 71% of them were for generic drugs. CMS names the drug for 595 of them, across 17 drugs with 11 or more claims each, at $218,538 in total drug cost. In 2023, CMS named 411 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Mankal for performance year 2024, reported as part of a group. Dr. Mankal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 119 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mankal, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Mankal, published from 2010 to 2019. 2014 was the busiest year, with 4. Dr. Mankal has published most often in ACG Case Rep J. Dr. Mankal's most frequent co-authors are Jean Abed, MD, Gagangeet S. Sandhu, MD and Vijay S. Dalapathi, MD.

CMS Open Payments shows 318 general payments to Dr. Mankal from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $1,866.

Dr. Mankal graduated from Ben Gurion University of the Negev in 2011.

Dr. Mankal is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.